Working… Menu
Trial record 20 of 140 for:    ZOLPIDEM

Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 1.75 mg Formulation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02814058
Recruitment Status : Completed
First Posted : June 27, 2016
Last Update Posted : June 8, 2018
Information provided by (Responsible Party):
Biolab Sanus Farmaceutica

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 22, 2018
Actual Study Completion Date : February 22, 2018